Latest Shareholder Participation News

Strategic Elements Ltd has received $1.2 million in applications under its Share Purchase Plan, surpassing its initial $1 million target and raising the cap to $2.5 million. The extra funds will accelerate development of its moisture-powered Energy Ink™ and operational intelligence platform EdgeiQ™.

AoFrio Limited is offering existing shareholders a 1-for-7 rights issue at NZ$0.07 per share following a NZ$4.56 million placement, aiming to raise nearly NZ$5 million to fund growth ambitions.

VRX Silica’s updated 2026 Bankable Feasibility Study for Arrowsmith North confirms robust economics with an ungeared NPV8 of A$179.2 million and binding offtake contracts securing nearly 1 million tonnes annually.

Bio-Gene Technology has raised A$3.21 million to complete critical safety studies for its novel insecticide Flavocide and ramp up production of its natural insecticide Qcide, advancing its path to commercialisation in multiple global markets.

Burley Minerals Ltd is offering eligible shareholders in Australia and New Zealand the chance to buy up to $30,000 of shares at a 17.9% discount through a $300,000 Share Purchase Plan, aiming to bolster its exploration funding without brokerage costs.

WAM Strategic Value Limited updates its fully franked interim dividend details for FY2026, confirming a 3.25 cent per share payout and clarifying its Dividend Reinvestment Plan pricing and mechanics.

Hawk Resources is raising up to $5.87 million through a placement and entitlement offer to fund drilling and soil sampling at its US copper and WA scandium projects. The raise includes a non-renounceable entitlement offer and options issuance, with dilution risks for non-participating shareholders.

AoFrio Limited has secured NZ$4.56 million through a share placement to existing investor Wairahi Investments, underpinning a bold strategy to boost revenue growth to 25% annually. A follow-up rights issue will allow current shareholders to participate at the same price.

Whitefield Income Limited is tapping shareholders for up to A$108 million through a discounted entitlement offer, reinforcing its commitment to steady dividend income amid solid financial performance.

Tanami Gold has launched a fully underwritten $70.5 million renounceable rights issue priced at 6 cents per share, aiming to finance its 50% stake in the Central Tanami Project. The offer is open to eligible shareholders across select jurisdictions and runs until 27 May 2026.

Atomo Diagnostics has closed a modest Share Purchase Plan, raising $44,500 and issuing free attaching options, while reserving a substantial shortfall for future placement.

Murray Cod Australia (ASX:MCA) has launched the retail tranche of its fully underwritten $18.6 million entitlement offer at a 43% discount, aiming to convert its record 3,700-tonne biomass into cash and expand processing capacity.